nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in Genomic and Proteomic Studies of Non–Small-Cell Lung Cancer: Clinical and Translational Research Perspective
|
Dziadziuszko, Rafal |
|
2008 |
9 |
2 |
p. 78-84 7 p. |
artikel |
2 |
Bevacizumab/Chemotherapy in Non–Small-Cell Lung Cancer: Looking for A Few Good Men?
|
Herbst, Roy S. |
|
2008 |
9 |
2 |
p. 75-76 2 p. |
artikel |
3 |
Complications of Ablative Therapies in Lung Cancer
|
Padda, Sukhmani |
|
2008 |
9 |
2 |
p. 122-126 5 p. |
artikel |
4 |
Cooperative Group Portfolio in Locally Advanced Non–Small-Cell Lung Cancer: Are We Making Progress?
|
Langer, Corey J. |
|
2008 |
9 |
2 |
p. 85-91 7 p. |
artikel |
5 |
Errata
|
|
|
2008 |
9 |
2 |
p. 77- 1 p. |
artikel |
6 |
High Incidence of Lung Cancer After Non–Muscle-Invasive Transitional Cell Carcinoma of the Bladder: Implications for Screening Trials
|
Rusthoven, Kyle E. |
|
2008 |
9 |
2 |
p. 106-111 6 p. |
artikel |
7 |
Management of Unresectable Stage III Non–Small-Cell Lung Cancer with Combined-Modality Therapy: A Review of the Current Literature and Recommendations for Treatment
|
Bayman, Neil A. |
|
2008 |
9 |
2 |
p. 92-101 10 p. |
artikel |
8 |
Population Characteristics and Prognostic Factors in Metastatic Non–Small-Cell Lung Cancer: A Fox Chase Cancer Center Retrospective
|
Paralkar, Vikram R. |
|
2008 |
9 |
2 |
p. 116-121 6 p. |
artikel |
9 |
Restrictive Eligibility Limits Access to Newer Therapies in Non–Small-Cell Lung Cancer: The Implications of Eastern Cooperative Oncology Group 4599
|
Somer, Robert A. |
|
2008 |
9 |
2 |
p. 102-105 4 p. |
artikel |
10 |
Selected Clinical Trials in Lung Cancer
|
Langer, Corey J. |
|
2008 |
9 |
2 |
p. 127-128 2 p. |
artikel |
11 |
Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Non–Small-Cell Lung Cancer
|
Koldas, Macit |
|
2008 |
9 |
2 |
p. 112-115 4 p. |
artikel |